Study Reveals Origins Of A Cancer Affecting The Blood And Bone Marrow
5/12/2011
A new study by the NYU Cancer Institute, an NCI-designated cancer center, sheds light on the origins of myeloid leukemia, a type of blood cancer that affects children and adults. The researchers discovered that novel mutations in an intracellular communication pathway called Notch led to the cancer, pointing to a potential new target for treating this disease...
European cancer experts have reported on developments of some promising radiosurgical techniques for treating lung and liver cancer using new linear accelerator technology from Varian Medical Systems (NYSE: VAR)...
Cell Therapeutics, Inc...
Great hopes are always placed in new cancer therapies. However, whether new surgical techniques, drugs or radiation therapies actually prolong the life of cancer patients, or even cure them, can often only be reliably assessed after several years' of testing...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the company submitted a New Drug Application for vemurafenib (RG7204, PLX4032) to the U.S...
Developer Of Leukemia Drug Gleevec To Speak At Moffitt Cancer Center
5/11/2011
Moffitt Cancer Center's 13th Annual Ted Couch Cancer Research Lecture will feature Brian J. Druker, M.D., director of the Oregon Health & Science University's Knight Cancer Institute, JELD-WEN Chair of Leukemia Research and investigator of the Howard Hughes Medical Institute, at 4 p.m. on May 26, in the Vincent A. Stabile Research Building, 12902 Magnolia Drive...
Lower Risk And Reduced Infection Offered By Pharmaceutical Advances
5/11/2011
Research presented at Digestive Disease Week® (DDW) shows that patients taking a blood thinner (clopidogrel) after having polyps removed during colonoscopy were at relatively low risk of bleeding...
Who Gets Treated Where For Colonoscopy, And How Effective Is That Treatment?
5/11/2011
Research presented at Digestive Disease Week® (DDW) continues to show the effectiveness of colonoscopy for the prevention and detection of colorectal cancer...
Oncolytics Biotech(R) Inc. Announces Phase I Multiple Myeloma Cancer Study
5/11/2011
Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that the Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute (NCI), which is part of the National Institutes of Health, has agreed to sponsor a Phase I study of REOLYSIN® alone in patients with relapsed multiple myeloma...
Helix BioPharma Corp. (TSX, NYSE Amex, FSE: "HBP"), a developer of biopharmaceutical drug candidates for the prevention and treatment of cancer, today announced the issuance of a patent (U.S. Patent No. 7,872,105 B2) by the United States Patent & Trademark Office for the non-small cell lung cancer ("NSCLC")- specific antibody component of its L-DOS47 drug candidate...